NP/PA Connect
News
Media
Around the PracticeBetween The LinesCase-Based Peer PerspectiveClinical Case CollectiveDermViewExpert PerspectivesFellows Face OffFrontline ForumMedical World NewsPatient PerspectivesPodcastsReadout360Recognize and Refer
Conferences
Conference CoverageConference Listing
Events
Case-Based Roundtable
More
Publication
Dermatology Times
CME/CE
Resources
DermIQInteractive ToolsJob BoardPartner PerspectivesPerspectives in DermatologyPollsSponsored ContentSponsored ResourcesSpot Test
Editorial Advisory Board
Partners

Subscribe

  • NP/PA Connect
  • News
  • Media
  • Conferences
  • Events
  • Publication
  • CME/CE
  • Resources
  • Editorial Advisory Board
  • Partners
  • Subscribe
  • Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
    • Non-Melanoma Skin Cancers
  • Vitiligo
  • Wound Care
Advertisement

Anna Bar, MD, FACMS

Advertisement

Articles by Anna Bar, MD, FACMS

Mohs for the Nose: Reconstruction Session Sneak Peek With Anna Bar, MD, FACMS

ByLauren Buchanan, MA, Managing Editor,Anna Bar, MD, FACMS
May 4th 2023

Bar will share insight on foldover interpolated flaps for full thickness of nasal defects.

Advertisement

Latest Updated Articles

  • Mohs for the Nose: Reconstruction Session Sneak Peek With Anna Bar, MD, FACMS
    Mohs for the Nose: Reconstruction Session Sneak Peek With Anna Bar, MD, FACMS

    Published: May 4th 2023 | Updated:



Advertisement
Advertisement

Trending on Dermatology Times

1

Icotrokinra Shows Superior Efficacy Over Advanced Oral Therapies in New Psoriasis Meta-Analysis

2

Kyowa Kirin Takes Full Control of Rocatinlimab Program

3

Phase 2 TYK2 Inhibition Shows Promise in AD

4

Dermatology Times January 2026 Recap

5

The Rx Recap: January 25-30

  • About
  • Advertise
  • Contact Us
  • Job Board
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy Policy
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us